Literature DB >> 32777171

A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis.

D M Baker1, A-M Folan2, M J Lee3,4, G L Jones2, S R Brown5, A J Lobo6.   

Abstract

AIM: Approximately 20%-30% of patients with ulcerative colitis (UC) will undergo surgery during their disease course, the vast majority being elective due to chronic refractory disease. The risks of elective surgery are reported variably. The aim of this systematic review and meta-analysis is to summarize the outcomes after elective surgery for UC.
METHODS: A systematic review was conducted that analysed studies reporting outcomes for elective surgery in the modern era (>2002). It was prospectively registered on the PROSPERO database (ref: CRD42018115513). Searches were performed of Embase and MEDLINE on 15 January 2019. Outcomes were split by operation performed. Primary outcome was quality of life; secondary outcomes were early, late and functional outcomes after surgery. Outcomes reported in five or more studies underwent a meta-analysis of incidence using random effects. Heterogeneity is reported with I2 , and publication bias was assessed using Doi plots and the Luis Furuya-Kanamori index.
RESULTS: A total of 34 studies were included (11 774 patients). Quality of life was reported in 12 studies, with variable and contrasting results. Thirteen outcomes (eight early surgical complications, five functional outcomes) were included in the formal meta-analysis, all of which were outcomes for ileal pouch-anal anastomosis (IPAA). A further 71 outcomes were reported (50 IPAA, 21 end ileostomy). Only 14 of 84 outcomes received formal definitions, with high inter-study variation of definitions.
CONCLUSION: Outcomes after elective surgery for UC are variably defined. This systematic review and meta-analysis highlights the range of reported incidences and provides practical information that facilitates shared decision making in clinical practice.
© 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  inflammatory bowel disease; outcomes research; surgery; ulcerative colitis

Year:  2020        PMID: 32777171     DOI: 10.1111/codi.15301

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  Effects of ethnicity and socioeconomic status on surgical outcomes from inflammatory bowel disease.

Authors:  Dimitrios Stamatiou; David N Naumann; Helen Foss; Rishi Singhal; Sharad Karandikar
Journal:  Int J Colorectal Dis       Date:  2022-05-13       Impact factor: 2.571

2.  Transmural Inflammation, Ileitis, and Granulomas at the Time of Proctocolectomy in Patients with Ulcerative Colitis Do Not Predict Future Development of Pouchitis.

Authors:  Edward L Barnes; Joshua Hudson; Scott Esckilsen; Bharati Kochar; Michael D Kappelman; Millie D Long; Mark Koruda; Robert S Sandler; Hans H Herfarth
Journal:  Inflamm Intest Dis       Date:  2021-10-07

Review 3.  Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review.

Authors:  Camilla Ronchetti; Federico Cirillo; Noemi Di Segni; Martina Cristodoro; Andrea Busnelli; Paolo Emanuele Levi-Setti
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

Review 4.  Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases.

Authors:  Lidiya V Boldyreva; Maryana V Morozova; Snezhanna S Saydakova; Elena N Kozhevnikova
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

5.  Cut-off value of ulcerative colitis endoscopic index of severity (UCEIS) score for predicting the need for pouch construction in ulcerative colitis: results of a multicenter study with long-term follow-up.

Authors:  Weimin Xu; Weijun Ou; Jihong Fu; Yubei Gu; Long Cui; Jie Zhong; Peng Du
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-05-29

6.  State-of-the-art surgery for ulcerative colitis.

Authors:  Shanglei Liu; Samuel Eisenstein
Journal:  Langenbecks Arch Surg       Date:  2021-08-28       Impact factor: 3.445

7.  Esculentoside A could attenuate apoptosis and inflammation in TNBS-induced ulcerative colitis via inhibiting the nuclear translocation of NF-κB.

Authors:  Ying Liu; Wenhua Wei; Shiwei Liang; Haicheng Fang; Jie Cao
Journal:  Ann Transl Med       Date:  2022-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.